This Week in Clinical Cancer Research | GenomeWeb

In Clinical Cancer Research this week, a team of US researchers writes that cyclin-dependent kinase 5 is amplified and over-expressed in pancreatic cancer. The team analyzed the expression of CDK5 and its activators, p35 and p39, during the progression of pancreatic cancer. The team observed amplification of CDK5, and either p35 or p39 in 67 percent of the human pancreatic ductal adenocarcinoma cell lines it studied.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.